Literature DB >> 24086685

S100A14 interacts with S100A16 and regulates its expression in human cancer cells.

Dipak Sapkota1, Daniela Elena Costea, Salah O Ibrahim, Anne C Johannessen, Ove Bruland.   

Abstract

Both S100A14 and S100A16 are members of the multifunctional S100 protein family. Formation of homo/heterodimers is considered to be one of the major mechanisms for S100 proteins to execute their diverse cellular functions. By employing a classical Yeast two hybrid (Y-2 H) screen, we identified S100A16 as the single interaction partner of S100A14. This interaction was verified by co-immunoprecipitation, double indirect immunofluorescence and double immunostaining in specimens of oral squamous cell carcinoma and normal oral mucosa. The functional significance of this interaction was examined by employing retroviral mediated over-expression and knock-down of these proteins in several cancer cell-lines. Over-expression and knock-down of S100A14 led to concomitant up- and down-regulation of S100A16 protein in the cell-lines examined. However, there was no up-regulation of S100A16 mRNA upon S100A14 over-expression, indicating that modulation of S100A16 expression was not due to enhanced transcriptional activity but possibly by post-transcriptional regulation. In contrary, over-expression of S100A16 was associated neither with the up-regulation of S100A14 mRNA nor its protein, suggesting a unidirectional regulation between S100A14 and S100A16. Cellular treatment with protein synthesis inhibitor cycloheximide demonstrated a time-dependent intracellular degradation of both S100A16 and S100A14 proteins. Additionally, regulation of S100A16 and S100A14 degradation was found to be independent of the classical proteasomal and lysosomal pathways of protein degradation. Further studies will therefore be necessary to understand the functional significance of this interaction and the mechanisms on how S100A14 is involved in the regulation of S100A16 expression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24086685      PMCID: PMC3785438          DOI: 10.1371/journal.pone.0076058

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  32 in total

Review 1.  The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction.

Authors:  Michael H Glickman; Aaron Ciechanover
Journal:  Physiol Rev       Date:  2002-04       Impact factor: 37.312

Review 2.  Endolysosomal proteolysis and its regulation.

Authors:  Ché S Pillay; Edith Elliott; Clive Dennison
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

3.  Molecular cloning and characterization of the human S100A14 gene encoding a novel member of the S100 family.

Authors:  Agnieszka Pietas; Karsten Schlüns; Ingo Marenholz; Beat W Schäfer; Claus W Heizmann; Iver Petersen
Journal:  Genomics       Date:  2002-04       Impact factor: 5.736

4.  Expression of the alphavbeta6 integrin promotes migration and invasion in squamous carcinoma cells.

Authors:  G J Thomas; M P Lewis; S A Whawell; A Russell; D Sheppard; I R Hart; P M Speight; J F Marshall
Journal:  J Invest Dermatol       Date:  2001-07       Impact factor: 8.551

5.  Calnuc, an EF-hand Ca(2+) binding protein, specifically interacts with the C-terminal alpha5-helix of G(alpha)i3.

Authors:  P Lin; T Fischer; T Weiss; M G Farquhar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 6.  The calpain family and human disease.

Authors:  Y Huang; K K Wang
Journal:  Trends Mol Med       Date:  2001-08       Impact factor: 11.951

7.  Oligomeric forms of the metastasis-related Mts1 (S100A4) protein stimulate neuronal differentiation in cultures of rat hippocampal neurons.

Authors:  V Novitskaya; M Grigorian; M Kriajevska; S Tarabykina; I Bronstein; V Berezin; E Bock; E Lukanidin
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

8.  Heterocomplex formation between metastasis-related protein S100A4 (Mts1) and S100A1 as revealed by the yeast two-hybrid system.

Authors:  S Tarabykina; M Kriajevska; D J Scott; T J Hill; D Lafitte; P J Derrick; G G Dodson; E Lukanidin; I Bronstein
Journal:  FEBS Lett       Date:  2000-06-23       Impact factor: 4.124

9.  Solution structure and dynamics of human S100A14.

Authors:  Ivano Bertini; Valentina Borsi; Linda Cerofolini; Soumyasri Das Gupta; Marco Fragai; Claudio Luchinat
Journal:  J Biol Inorg Chem       Date:  2012-11-30       Impact factor: 3.358

Review 10.  S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles.

Authors:  R Donato
Journal:  Int J Biochem Cell Biol       Date:  2001-07       Impact factor: 5.085

View more
  8 in total

1.  S100A14 Is Increased in Activated NK Cells and Plasma of HIV-Exposed Seronegative People Who Inject Drugs and Promotes Monocyte-NK Crosstalk.

Authors:  Krystal Colón; David W Speicher; Peter Smith; Mack Taylor; David S Metzger; Luis J Montaner; Costin Tomescu
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731

Review 2.  Certainty of S100 from Physiology to Pathology.

Authors:  Puneeth Horatti Kuberappa; Bhavana Shivanand Bagalad; Anuradha Ananthaneni; Md Asif Kiresur; Guduru Vijay Srinivas
Journal:  J Clin Diagn Res       Date:  2016-06-01

3.  S100A16 promotes differentiation and contributes to a less aggressive tumor phenotype in oral squamous cell carcinoma.

Authors:  Dipak Sapkota; Ove Bruland; Himalaya Parajuli; Tarig A Osman; Muy-Teck Teh; Anne C Johannessen; Daniela Elena Costea
Journal:  BMC Cancer       Date:  2015-09-09       Impact factor: 4.430

4.  Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.

Authors:  Mizuko Tanaka; Naoki Ichikawa-Tomikawa; Namiko Shishito; Keisuke Nishiura; Tomiko Miura; Ayumi Hozumi; Hideki Chiba; Sayaka Yoshida; Tohru Ohtake; Takashi Sugino
Journal:  BMC Cancer       Date:  2015-02-13       Impact factor: 4.430

5.  Differentially expressed genes in preimplantation human embryos: potential candidate genes for blastocyst formation and implantation.

Authors:  Erika M Munch; Amy E Sparks; Jesus Gonzalez Bosquet; Lane K Christenson; Eric J Devor; Bradley J Van Voorhis
Journal:  J Assist Reprod Genet       Date:  2016-05-30       Impact factor: 3.412

6.  S100A16 suppresses the proliferation, migration and invasion of colorectal cancer cells in part via the JNK/p38 MAPK pathway.

Authors:  Shiyu Ou; Yan Liao; Jie Shi; Jing Tang; Yanqing Ye; Fengfei Wu; Weidong Wang; Jieying Fei; Fang Xie; Lan Bai
Journal:  Mol Med Rep       Date:  2020-12-23       Impact factor: 2.952

7.  The role of S100A14 in epithelial ovarian tumors.

Authors:  Hanbyoul Cho; Ha-Yeon Shin; Sunghoon Kim; Jane Seon-Young Kim; Joon-Yong Chung; Eun Joo Chung; Kyung-Hee Chun; Stephen M Hewitt; Jae-Hoon Kim
Journal:  Oncotarget       Date:  2014-06-15

8.  Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.

Authors:  Linjie Luo; Chao Liang
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.